CRVL

Business Context and Reporting Period

Company: CorVel Corp.
Filing Type: Form 10-Q (Quarterly Report)
Reporting Period: Quarter and nine months ended December 31, 2001.
Business Overview: CorVel provides managed care services, primarily in the workers' compensation industry, including bill review, utilization management, and PPO services. The company operates in a regulated environment subject to state licensing and evolving healthcare legislation.

Key Financial Metrics

Margins (Three Months Ended Dec 31, 2001):

• Gross Margin: 18.2%
• Net Income Margin: 6.4%

Material Changes vs. Prior Period

Revenue Growth:

• Quarterly: Revenues increased 12% to $58.7 million from $52.2 million in the prior year quarter.
• Year-to-Date: Revenues increased 13% to $175.2 million from $154.5 million in the prior year period.

Driver of Growth: The increase is primarily attributable to a 22% quarterly and 26% year-to-date increase in provider program revenues (bill review and PPO), driven by higher volumes of bills reviewed.

Expenses:

• Cost of Revenues: Decreased as a percentage of revenue from 82.7% to 81.8% for the quarter; remained flat at 82.0% for the nine-month period.
• General and Administrative (G&A): Increased as a percentage of revenue from 7.4% to 7.9% for the quarter due to increased MIS staff supporting the implementation of CareMC and electronic data interfaces.

Capital Structure: The company executed a 3-for-2 common stock split (50% stock dividend) in August 2001. All share and per-share data have been restated to reflect this split.

Outlook, Risks, and Management Commentary

Liquidity and Capital Resources:

• The company has no interest-bearing debt.
• Cash and cash equivalents totaled $12.3 million as of December 31, 2001.
• Management believes current cash balances and internally generated funds are sufficient to meet requirements for the next twelve months.
• Net working capital increased by $1.1 million to $36.2 million during the nine-month period.

Strategic Initiatives:

• Continued investment in MIS staff and software (CareMC) to improve data processing and electronic interfaces.
• Exploration of the group health market, though the company notes limited experience and high competition in this sector.

Risk Factors:

• Regulation: Subject to state licensing and evolving workers' compensation laws. Potential legislative reforms (e.g., 24-hour health coverage) could adversely affect demand.
• Competition: Faces competition from large insurers, HMOs, and PPOs with greater financial resources.
• Legal Liability: Potential exposure to litigation regarding medical treatment recommendations, though the company maintains professional liability insurance.
• Market Dynamics: Declines in workers' compensation claim costs in some states could reduce demand for services.

Accounting Pronouncements: The company is evaluating the impact of SFAS No. 141 (Business Combinations) and SFAS No. 142 (Goodwill), expecting adoption of SFAS 142 in fiscal 2003. SFAS 143 and 144 are not expected to have a significant impact.

Investor Verification Checklist

• Revenue Quality: Verify the sustainability of the 22% growth in provider program revenues and the volume of bills reviewed.
• Expense Management: Monitor G&A expenses as a percentage of revenue, which rose to 7.9% due to technology investments.
• Regulatory Exposure: Assess the impact of state-specific licensing requirements and potential federal or state healthcare legislative changes on the business model.
• Debt-Free Status: Confirm the company's ability to fund future growth and acquisitions solely through operating cash flow and equity, given the lack of debt financing.
• Stock Split Impact: Ensure all historical comparisons account for the 3-for-2 stock split executed in August 2001.